Belite Bio to Host Webcast on May 11, 2023 to Discuss First Quarter 2023 Financial Results
SAN DIEGO, May 10, 2023 (GLOBE NEWSWIRE) -- Belite Bio, Inc BLTE, a clinical stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting retinal degenerative eye diseases which have significant unmet medical needs, …